Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
clinical trials
life sciences
national
national blog main
national top stories
new york top stories
roche
3
×
san francisco top stories
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
merck
new england journal of medicine
new york blog main
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
What
drug
new
3
×
approved
fda
medicine
patients
advantages
atrophy
bar
bio
brings
cancer
daily
deeper
dna
evrysdi
expect
fingerprint
friday
gamble
genetic
going
green
home
intended
lights
liquid
market
matter
medco’s
mover
muscular
nd
oks
oral
payers
physicians
plan
pricing
risdiplam
Language
unset
Current search:
roche
×
photo
×
" san francisco top stories "
×
new
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues